Frontage Holdings Corp
HKEX:1521

Watchlist Manager
Frontage Holdings Corp Logo
Frontage Holdings Corp
HKEX:1521
Watchlist
Price: 1.67 HKD 0.6% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
Frontage Holdings Corp?
Write Note

Frontage Holdings Corp
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Frontage Holdings Corp
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Frontage Holdings Corp
HKEX:1521
Cash Interest Paid
$7.1m
CAGR 3-Years
48%
CAGR 5-Years
80%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash Interest Paid
$383m
CAGR 3-Years
1%
CAGR 5-Years
25%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Cash Interest Paid
$80m
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
-6%
IQVIA Holdings Inc
NYSE:IQV
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Frontage Holdings Corp
Glance View

Market Cap
3.4B HKD
Industry
Life Sciences Tools & Services

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.

Intrinsic Value
2.65 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Frontage Holdings Corp's Cash Interest Paid?
Cash Interest Paid
7.1m USD

Based on the financial report for Dec 31, 2023, Frontage Holdings Corp's Cash Interest Paid amounts to 7.1m USD.

What is Frontage Holdings Corp's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
80%

Over the last year, the Cash Interest Paid growth was 79%. The average annual Cash Interest Paid growth rates for Frontage Holdings Corp have been 48% over the past three years , 80% over the past five years .

Back to Top